DrugsControl Media Services

News Detail

'Poorly designed': ICMR distances itself from BHU's study on Covaxin (21-05-2024)

New Delhi, 21 May 2024: The Indian Council of Medical Research (ICMR) on Monday distanced itself from BHU's study on Covaxin and called it "poorly designed". ICMR Director General Dr Rajiv Bahl wrote a letter to the authors of the paper and editor of the journal to immediately re......
View Details

Source : Business Today
ICMR Covaxin BHU Study Side Effects Covaxin Controversy Vaccine Safety AESIs Bharat Biotech COVID-19 Vaccine Vaccine Adverse Events Covaxin Side Effects Dr Rajiv Bahl Springer Nature Journal Medical Research Adverse Events of Special Interest Covishield AstraZeneca Vaccine-Associated Incidents Ministry of Health India Long-Term Vaccine Safety

Related News